RUTGERS, THE STATE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

HRV Biofeedback in Fibromyalgia

Not Applicable

Completed

Conditions: Fibromyalgia Syndrome

Interventions: Behavioral: RSA Biofeedback
Behavioral: EEG Biofeedback Condition

First Posted Date: 2005-09-22

Last Posted Date: 2015-02-09

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 80

Registration Number: NCT00222274

Locations: 🇺🇸
UMDNJ-Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States

Licorice Root Extract and Docetaxel in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Phase 2

Terminated

Conditions: Prostate Cancer

Interventions: Dietary Supplement: licorice root extract
Drug: docetaxel

First Posted Date: 2005-09-15

Last Posted Date: 2023-12-22

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 10

Registration Number: NCT00176631

Locations: 🇺🇸
Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer

Phase 2

Terminated

Conditions: Kidney Cancer

Interventions: Biological: therapeutic allogeneic lymphocytes

First Posted Date: 2005-09-15

Last Posted Date: 2014-01-06

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 3

Registration Number: NCT00176501

Locations: 🇺🇸
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States

CINJALL: Treatment for Children With Acute Lymphocytic Leukemia

Phase 2

Completed

Conditions: Acute Lymphocytic Leukemia

Interventions: Drug: L-asparaginase
Drug: aminopterin
Drug: daunomycin
Drug: dexamethasone
Drug: cyclophosphamide
Drug: 6-mercaptopurine
Drug: cytarabine
Drug: methotrexate
Drug: vincristine
Drug: Triple Intrathecal Therapy (MTX, Cytarabine, Hydrocortisone)
Drug: Leucovorin
Drug: 6-thioguanine

First Posted Date: 2005-09-15

Last Posted Date: 2014-06-09

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 60

Registration Number: NCT00176462

Locations: 🇺🇸
Jersey Shore University Medical Center, Neptune, New Jersey, United States
🇺🇸
Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

Phase II Metronomic Dosing, Etoposide, Cyclophosphamide, D0 Prostate Cancer

Phase 2

Completed

Conditions: Prostate Cancer

Interventions: Drug: Etoposide
Drug: Cyclophosphamide

First Posted Date: 2005-09-15

Last Posted Date: 2014-05-20

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 15

Registration Number: NCT00176605

Locations: 🇺🇸
UMDNJ/Robert Wood Johnson Medical School, Newark, New Jersey, United States
🇺🇸
Robert Wood Johnson University Hospital/CINJ at Hamilton, Hamilton, New Jersey, United States
🇺🇸
Morristown Memorial Hospital, Morristown, New Jersey, United States

and more 4 locations

The Use of Capnography as a Guide for Oral Intubation

Terminated

Conditions: Measurement

Interventions: Procedure: Capnography

First Posted Date: 2005-09-15

Last Posted Date: 2017-01-27

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 20

Registration Number: NCT00176683

Locations: 🇺🇸
New Jersey Medical School, Newark, New Jersey, United States

Gene Expression During Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Choline Magnesium Trisalicylate

Phase 1

Terminated

Conditions: Leukemia

Interventions: Drug: choline magnesium trisalicylate
Drug: Dexamethasone

First Posted Date: 2005-09-12

Last Posted Date: 2013-11-19

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 15

Registration Number: NCT00156299

Locations: 🇺🇸
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States

Effectiveness of Cognitive-Affective Behavior Therapy for the Treatment of Somatization Disorder

Phase 2

Completed

Conditions: Somatization Disorder

Interventions: Behavioral: Cognitive-Affective Behavior Therapy
Behavioral: Augmented Standard Medical Care

First Posted Date: 2005-09-08

Last Posted Date: 2014-02-20

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 88

Registration Number: NCT00149760

Locations: 🇺🇸
Department of Psychiatry, Robert Wood Johnson Medical School, Piscataway, New Jersey, United States

Green Tea and Ultraviolet Light-induced Skin Damage

Phase 2

Terminated

Conditions: Healthy

Interventions: Drug: Green Tea
Drug: Placebo

First Posted Date: 2005-08-24

Last Posted Date: 2017-09-06

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 68

Registration Number: NCT00134381

Locations: 🇺🇸
UMDNJ Division of Clinical Pharmacology, New Brunswick, New Jersey, United States

Calcitriol in Preventing Prostate Cancer in Patients With Prostatic Intraepithelial Neoplasia

Phase 2

Terminated

Conditions: Precancerous/Nonmalignant Condition
Prostate Cancer

Interventions: Dietary Supplement: calcitriol
Procedure: observation

First Posted Date: 2005-07-11

Last Posted Date: 2015-05-27

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 12

Registration Number: NCT00118066

Locations: 🇺🇸
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States
🇺🇸
Saint Peter's University Hospital, New Brunswick, New Jersey, United States
🇺🇸
Central Jersey Oncology Center, PA - East Brunswick, East Brunswick, New Jersey, United States

and more 2 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy